Lead researcher
A/Prof Phillip Darcy, A/Prof Michael Kershaw
Institution
Cancer Immunology Research, Peter MacCallum Cancer Centre
Years funded
2015-2017
White blood cells from cancer
patients can be modified in the laboratory to react against tumours. However
the poor trafficking of these cells to the tumour site and the fact that cancer
cells can effectively turn off these gene-modified cells has hampered this
approach. We propose to fully address these two critical issues using
innovative techniques and mouse models that closely recapitulate the human setting.
We anticipate that these studies will lead to a more effective therapy for
patients.
Funding Body
Cancer Council Research Grant
Award / Duration
Bruce Ward Grant-in-Aid
Funding
$100,000 per annum